1: Park JJH, Mogg R, Smith GE, Nakimuli-Mpungu E, Jehan F, Rayner CR, Condo J, Decloedt EH, Nachega JB, Reis G, Mills EJ. How COVID-19 has fundamentally changed clinical research in global health. Lancet Glob Health. 2021 May;9(5):e711-e720. doi: 10.1016/S2214-109X(20)30542-8. PMID: 33865476; PMCID: PMC8049590.

https://pubmed.ncbi.nlm.nih.gov/33865476/

 

2: Reis G, Moreira Silva EADS, Medeiros Silva DC, Thabane L, Singh G, Park JJH, Forrest JI, Harari O, Quirino Dos Santos CV, Guimarães de Almeida APF, Figueiredo Neto AD, Savassi LCM, Milagres AC, Teixeira MM, Simplicio MIC, Ribeiro LB, Oliveira R, Mills EJ; TOGETHER Investigators. Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical Trial. JAMA Netw Open. 2021 Apr 1;4(4):e216468. doi: 10.1001/jamanetworkopen.2021.6468. PMID: 33885775.

https://pubmed.ncbi.nlm.nih.gov/33885775/

 

3: Lee Z, Rayner CR, Forrest JI, Nachega JB, Senchaudhuri E, Mills EJ. The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19. Am J Trop Med Hyg. 2021 Jan;104(1):35-38. doi: 10.4269/ajtmh.20-1320. PMID: 33236703; PMCID: PMC7790108. 

https://pubmed.ncbi.nlm.nih.gov/33236703/

4: Nachega JB, Ishoso DK, Otokoye JO, Hermans MP, Machekano RN, Sam-Agudu NA, Bongo-Pasi Nswe C, Mbala-Kingebeni P, Madinga JN, Mukendi S, Kolié MC, Nkwembe EN, Mbuyi GM, Nsio JM, Mukeba Tshialala D, Tshiasuma Pipo M, Ahuka-Mundeke S, Muyembe-Tamfum JJ, Mofenson L, Smith G, Mills EJ, Mellors JW, Zumla A, Mavungu Landu DJ, Kayembe JM. Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo. Am J Trop Med Hyg. 2020 Dec;103(6):2419-2428. doi: 10.4269/ajtmh.20-1240. Epub 2020 Oct 2. PMID: 33009770; PMCID: PMC7695108.

https://pubmed.ncbi.nlm.nih.gov/33009770/

5: Park JJH, Decloedt EH, Rayner CR, Cotton M, Mills EJ. Clinical trials of disease stages in COVID 19: complicated and often misinterpreted. Lancet Glob Health. 2020 Oct;8(10):e1249-e1250. doi: 10.1016/S2214-109X(20)30365-X. Epub 2020 Aug 20. PMID: 32828171; PMCID: PMC7440858.

https://pubmed.ncbi.nlm.nih.gov/32828171/

6: Dillman A, Park JJH, Zoratti MJ, Zannat NE, Lee Z, Dron L, Hsu G, Smith G, Khakabimamaghani S, Harari O, Thorlund K, Mills EJ. Reporting and design of randomized controlled trials for COVID-19: A systematic review. Contemp Clin Trials. 2020 Dec 3;101:106239. doi: 10.1016/j.cct.2020.106239. Epub ahead of print. PMID: 33279656.

https://pubmed.ncbi.nlm.nih.gov/33279656/

7: Rayner CR, Dron L, Park JJH, Decloedt EH, Cotton MF, Niranjan V, Smith PF, Dodds MG, Brown F, Reis G, Wesche D, Mills EJ. Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19. Am J Trop Med Hyg. 2020 Oct;103(4):1364-1366. doi: 10.4269/ajtmh.20-0995. PMID: 32828137; PMCID: PMC7543863.

https://pubmed.ncbi.nlm.nih.gov/32828137/

8: Dillman A, Zoratti MJ, Park JJH, Hsu G, Dron L, Smith G, Harari O, Rayner CR, Zannat NE, Gupta A, Mackay E, Arora P, Lee Z, Mills EJ. The Landscape of Emerging Randomized Clinical Trial Evidence for COVID-19 Disease Stages: A Systematic Review of Global Trial Registries. Infect Drug Resist. 2020 Dec 22;13:4577-4587. doi: 10.2147/IDR.S288399. PMID: 33376364; PMCID: PMC7764888.

https://pubmed.ncbi.nlm.nih.gov/33376364/

9: Forrest JI, Rayner CR, Park JJH, Mills EJ. Early Treatment of COVID-19 Disease: A Missed Opportunity. Infect Dis Ther. 2020 Oct 13:1-6. doi: 10.1007/s40121-020-00349-8. Epub ahead of print. Erratum in: Infect Dis Ther. 2020 Nov 9;:1. PMID: 33072490.

https://pubmed.ncbi.nlm.nih.gov/33072490/

10: Thorlund K, Dron L, Park J, Hsu G, Forrest JI, Mills EJ. A real-time dashboard of clinical trials for COVID-19. Lancet Digit Health. 2020 Jun;2(6):e286-e287. doi: 10.1016/S2589-7500(20)30086-8. Epub 2020 Apr 24. PMID: 32363333; PMCID: PMC7195288.

https://pubmed.ncbi.nlm.nih.gov/32363333/

11: Nachega JB, Leisegang R, Kallay O, Mills EJ, Zumla A, Lester RT. Mobile Health Technology for Enhancing the COVID-19 Response in Africa: A Potential Game Changer? Am J Trop Med Hyg. 2020 Jul;103(1):3-5. doi: 10.4269/ajtmh.20-0506. Epub 2020 May 29. PMID: 32476643; PMCID: PMC7356462.

https://pubmed.ncbi.nlm.nih.gov/32476643/

12: Abena PM, Decloedt EH, Bottieau E, Suleman F, Adejumo P, Sam-Agudu NA, Muyembe TamFum JJ, Seydi M, Eholie SP, Mills EJ, Kallay O, Zumla A, Nachega JB. Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings. Am J Trop Med Hyg. 2020 Jun;102(6):1184-1188. doi: 10.4269/ajtmh.20-0290. PMID: 32323646; PMCID: PMC7253100.

https://pubmed.ncbi.nlm.nih.gov/32323646/